Monoamine clearance is a combined function of uptake mechanisms in the plasma membrane with intracellular metabolizing enzymes. Two different uptake mechanisms have been described. Uptake 1 is located in presynaptic neurones, whereas uptake 2 is extraneuronal. Recently, the Slc22a3/Orct3 gene was identi®ed as the extraneuronal monoamine transporter. In mouse embryonic development Orct3 expression is restricted to the placenta, which is also a site of expression of neuronal transporters. We have used RNA blots and in situ hybridization to examine the expression of Orct3 and other members of the monoamine uptake and metabolizing pathways in mouse placenta. The results show that Orct3 expression overlaps that of the monoamine metabolizing enzyme Maoa in the labyrinth layer of the placenta with an expression pattern distinct from that of the neuronal transporters Slc6a2/Net and Slc6a4/Sert. q
Results
Recently, the Slc22a3 (Orct3/Oct3/EMT) gene has been identi®ed in mouse, rat, and man (Grundemann et al., 1998; Kekuda et al., 1998; Verhaagh et al., 1999) . Both rat and human Orct3 have the capacity to transport monoamines in vitro (Grundemann et al., 1998; Wu et al., 1998) . Based on kinetic parameters, inhibitor pro®le and expression pattern, it was proposed that Orct3 is the extraneuronal monoamine transport system known as uptake 2 , that is involved in inactivating monoamines (Grundemann et al., 1998; Trendelenburg, 1988) . Northern blot analysis has shown that Orct3 is expressed abundantly and uniquely in placenta during mouse embryonic development Verhaagh et al., 1999) .
RNA in situ hybridization shows expression of Orct3 in a subset of cells in placenta at day 12.5 of development (Fig.  1A,B) . Hybridization of adjacent sections shows that the Orct3 expression pattern resembled that of the labyrinth trophoblast marker Tfeb ( Fig. 1D ; Steingrimsson et al., 1998) but not that of Mash2 (Fig. 1C) , which is expressed in the spongiotrophoblast (Guillemot et al., 1994) . Thus, Orct3 expression is restricted to the labyrinth layer, where trophoblast cells are in contact with both the maternal and the foetal circulation to allow an exchange of nutrients, gases and waste products.
Monoamine clearance by the placenta from both the maternal and the foetal circulation has been described (reviewed in Ganapathy et al., 1993; Nguyen et al., 1999) . Northern blot analysis of human placenta has also shown the expression of the neuronal transporters NET (noradrenaline transporter) and SERT (serotonin transporter) (Prasad et al., 1996; Ramamoorthy et al., 1993a,b) . In addition, biochemical and immunohistochemical studies have shown that the intracellular enzymes, catechol-O-methyltransferase (COMT) and monoamine oxidase A (MAOA), that inactivate monoamines after transport across the cell membrane, are also present in the human placenta (Morgan et al., 1972; Saarikoski, 1974; Thorpe et al., 1987; Trendelenburg, 1988) . However, with the exception of MAOA, the cell types in the human placenta that express these transporters and metabolizing enzymes have not been identi®ed. To gain more insight into the process of monoamine clearance in the mouse placenta, the expression of monoamine transporters and metabolizing enzymes was studied by Northern blot and in situ hybridization.
Northern blot analysis shows that besides Orct3, the speci®c transporters for noradrenaline (Net) and serotonin (Sert) are expressed in mouse placenta (Fig. 2) . A decline in the expression of Orct3 was seen towards the end of gestation ( Fig. 2 ; Verhaagh et al., 1999) . The expression of Net also showed a slight decrease in later stages in contrast to the expression of Sert that shows a large increase at day 18.5. Finally, no expression of the dopamine transporter (Slc6a3/Dat, data not shown) could be detected. Of the metabolizing enzymes, Maoa expression showed a decline with developmental age that was very similar to that of Orct3, whereas Comt levels were not developmentally regulated. These results show that both uptake 1 and uptake 2 components as well as the metabolizing enzymes are present and developmentally regulated in the mouse placenta.
To determine the cellular expression pattern of these monoamine clearance components in placenta, RNA in situ hybridization was performed at two developmental stages. At day 12.5 of gestation, the neuronal transporter Net was expressed primarily in the endothelial cells surrounding the maternal blood sinuses in the decidua basalis. Lower levels were detected in trophoblast giant cells and in large rounded cells in the labyrinth layer (Fig. 3A) . At day 17.5, Net expression is no longer detected in the giant cells and in the labyrinth layer, but expression in the decidual endothelial cells remains high (Fig. 3E) . In contrast to Net, Sert expression was seen in a small number of solitary cells in the labyrinth at day 12.5 of development (Fig. 3B) . The increase of Sert expression during late gestation is the result of an induction in the spongiotrophoblast layer (Fig.  3F) . Comparison of 12.5 and 17.5 dpc placental sections shows that Orct3 is expressed in a reduced number of cells in the labyrinth layer at later gestation (Fig. 3C,G) . These results show that the monoamine transporters Net, Sert, and Orct3 are located in different compartments in the mouse placenta. Furthermore, the in situ data provide support for the functional activities described for NET and SERT at the maternal side of the human placenta based on brush border vesicles (Balkovetz et al., 1989; Ramamoorthy et al., 1992 Ramamoorthy et al., , 1993b . For the metabolizing enzyme Comt, sensitivity fell below detection levels in placenta (data not shown). Maoa expression was detected in the labyrinth layer at day 12.5 in a pattern that overlapped that of Orct3 (Fig.  3C,D) but was reduced below detection levels at 17.5 dpc (Fig. 3H) .
These results show that monoamine uptake and metabolizing pathways are present in the mouse placenta. The uptake 1 transporter Net is expressed primarily in endothelial cells surrounding the maternal blood sinuses in the decidua basalis. The expression of the uptake 2 extraneuronal monoamine transporter Orct3, co-localizes with the monoamine metabolizing enzyme Maoa in the labyrinth layer, where trophoblast cells mediate transport from both the maternal and foetal circulation. The co-localization of Orct3 and Maoa and their synchronous developmental regulation indicates the presence of a monoamine clearance pathway in mouse placenta. Mice, in which Orct3 is inactivated by homologous recombination, will provide an in vivo model to test the role of Orct3 in placental monoamine transport.
Materials and methods

RNA in situ hybridization
Diogoxigenin-labelled probes were generated from the following cDNA fragments: mOrct3 from 2766 to 3499 mComt from 723 to 1197 and from 178 to 802 (Accession No. AF076156). RNA in situ hybridization was performed on 20 mm cryosections of day 12.5 and 17.5 pc mouse placentas as previously described (Giger et al., 1996) .
Northern blotting
RNA was isolated by lithium chloride extraction (Auffray and Rougeon, 1980) , and analyzed on formaldehyde-agarose gels. Hybridizations were performed as described (Church and Gilbert, 1984) . Fragments described above were used as probes. The mouse Pai1 gene (Accession No. M33960) was used as a loading control. providing placental RNA samples, and J. Bulthuis for preparation of cryosections. This work was supported by a grant from the Dutch Cancer Society (KWF).
